Bilobalide inhibits 6-OHDA-induced activation of NF-κB and loss of dopaminergic neurons in rat substantia nigra

AbstractAim:To investigate the effects of bilobalide on the activation of NF-κB, and apoptosis of dopaminergic neurons induced by 6-hydroxydopamine (6-OHDA).Methods:A rat model of Parkinson's disease was produced with a unilateral infusion of 6-OHDA (8 μg) into the substantia nigra par compact. Bilobalide was administered 5, 10, and 20 mg/kg (ip) once a day for 7 d, starting 6 d prior to the 6-OHDA infusion. The rats were subjected to locomotor activity and rotational behavior testing 2 or 3 weeks after the 6-OHDA infusion. The expressions of tyrosine hydroxylase (TH) and NF-κB p65 were examined by immunofluorescence. The loss of dopaminergic neurons was detected by Nissl's staining. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling was used to identify apoptosis.Results:The behavioral changes due to 6-OHDA were significantly restored by bilobalide pretreatment. Bilobalide inhibited the 6-OHDA-induced loss of TH-positive neurons, decreased the activation of NF-κB, and protected dopaminergic neurons from apoptosis remarkably.Conclusion:NF-κB activation contributes to the 6-OHDA-induced loss of dopaminergic neurons, and the inhibition of the NF-κB pathway is likely to be involved in the neuroprotective effect of bilobalide.

[1]  Y. Christen,et al.  EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer's disease , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  T. Chase,et al.  NF-κB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53 , 2007, Brain Research.

[3]  S. Dolan,et al.  Oral administration of Ginkgo biloba extract, EGb‐761 inhibits thermal hyperalgesia in rodent models of inflammatory and post‐surgical pain , 2007, British journal of pharmacology.

[4]  V. Kumar,et al.  Bilobalide prevents ischemia-induced edema formation in vitro and in vivo , 2007, Neuroscience.

[5]  M. Vacca,et al.  Ginkgo biloba Leaf Extract Reverses Amyloid β-Peptide-Induced Isoprostane Production in Rat Brain in vitro , 2006, Planta medica.

[6]  Yongmoon Han.  Ginkgo terpene component has an anti-inflammatory effect on Candida albicans-caused arthritic inflammation. , 2005, International immunopharmacology.

[7]  J. Andersen,et al.  Cell in focusDopaminergic neurons , 2005 .

[8]  Rajnish Kumar Chaturvedi,et al.  Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences , 2005, Journal of neurochemistry.

[9]  E. Tercan,et al.  Antioxidant effect of EGb 761 on hydrogen peroxide‐induced lipoperoxidation of G‐6‐PD deficient erythrocytes , 2004, Phytotherapy research : PTR.

[10]  Y. Oh,et al.  Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant. , 2004, Biochemical and biophysical research communications.

[11]  L. Siklós,et al.  The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease , 2004 .

[12]  Markus Schwaninger,et al.  The role of NF-κB in 6-hydroxydopamine- and TNFα-induced apoptosis of PC12 cells , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[13]  J. Dichgans,et al.  Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation , 2003 .

[14]  B. Ahlemeyer,et al.  Neuroprotective effects of Ginkgo biloba extract , 2003, Cellular and Molecular Life Sciences CMLS.

[15]  G. Fiskum,et al.  Neuroprotective Effects of Bilobalide, a Component of Ginkgo biloba Extract (EGb 761®) in Global Brain Ischemia and in Excitotoxicity-induced Neuronal Death , 2003 .

[16]  B. Ahlemeyer,et al.  Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s Disease , 2003, Pharmacopsychiatry.

[17]  G. Fiskum,et al.  Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. , 2002, Cellular and molecular biology.

[18]  M. Grundman,et al.  Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.

[19]  J. Remacle,et al.  Mitochondrial respiratory chain as a new target for anti-ischemic molecules. , 2002, European journal of pharmacology.

[20]  G. Fiskum,et al.  Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia , 2001, Brain Research.

[21]  A. Barzilai,et al.  Is There a Rationale for Neuroprotection Against Dopamine Toxicity in Parkinson's Disease? , 2001, Cellular and Molecular Neurobiology.

[22]  A. Barzilai,et al.  Activation of nuclear transcription factor kappa B (NF‐κB) is essential for dopamine‐induced apoptosis in PC12 cells , 2001, Journal of neurochemistry.

[23]  F. V. Defeudis,et al.  Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. , 2000, Current drug targets.

[24]  L. Zhou,et al.  Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. , 2000, The Journal of pharmacology and experimental therapeutics.

[25]  C. Michiels,et al.  Protection by bilobalide of the ischaemia‐induced alterations of the mitochondrial respiratory activity , 2000, Fundamental & clinical pharmacology.

[26]  Y. Christen,et al.  In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extrac3t (EGb 761) , 2000, Mechanisms of Ageing and Development.

[27]  M. Hilgert,et al.  Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[28]  S. Mandel,et al.  The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators , 1999, Annals of the New York Academy of Sciences.

[29]  Z. Qin,et al.  Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats. , 1999, Molecular pharmacology.

[30]  Xing-zu Zhu,et al.  Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. , 1999, Life sciences.

[31]  T. Chase,et al.  Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.

[32]  B. Ahlemeyer,et al.  Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. , 1999, European journal of pharmacology.

[33]  Y Agid,et al.  Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Chatterjee,et al.  Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba , 1997, Brain Research.

[35]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[36]  Fred H. Gage,et al.  Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior , 1991, Brain Research.

[37]  Cao Fei,et al.  Experimental study on inhibition of neuronal toxical effect of Levodopa by Ginkgo Biloba Extract on Parkinson disease in rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[38]  G. Kreutzberg,et al.  Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema , 2004, Acta Neuropathologica.

[39]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.

[40]  J. Westman,et al.  Antioxidant compounds EGB-761 and BN-52021 attenuate brain edema formation and hemeoxygenase expression following hyperthermic brain injury in the rat. , 2003, Acta neurochirurgica. Supplement.

[41]  S. Mandel,et al.  Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures. , 2002, Biochemical pharmacology.

[42]  R. Xiu,et al.  The therapeutic effect of Ginkgo biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. , 2000, Clinical hemorheology and microcirculation.

[43]  A. Wettstein.  Cholinesterase inhibitors and Ginkgo extracts — are they comparable in the treatment of dementia? , 2000 .

[44]  T. Chase,et al.  Nuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum , 1998 .

[45]  I. Ziv,et al.  Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process? , 1997, Journal of neural transmission. Supplementum.